marine bioprospecting - Novel Drugs from the Sea

Key People




Nils Spidsøe 
– Chairman of Board of Directors. Technologist, Marine Technology.

Nils has 40 years experiences in SINTEF within technological R&D, R&D management and technology transfer, hereunder establishment and financing of a number of successful spin off companies from SINTEF within a variety technology sectors. He was engaged in SINTEF s marine bioprospecting program in the period 2004-2009, which lead to the establishment of MarBiLeads AS in 2010. He was also representing SINTEF in the development of the Norwegian national strategy for marine bioprospecting and the national R&D program Biotech2021.

e-mail: Nils.Spidsoe@sintef.no



Ola Flink
– Member of Board of Directors. Pharmacist.

Ola brings experience from more than 30 years in the pharmaceutical drug development industry, including AstraZeneca, Apoteksbolaget, ACO Läkemedel and Kabi Invent. Previous appointments include CEO of Karolinska Institutet Innovations AB, investment manager at Karolinska Development AB with several Board assignments, including chairman of the Board of Biosergen AS.



Ole-Martin Gulliksen
– CEO. Cell biologist.

Ole-Martin has broad background from academia (10 years as scientist and lecturer at the University of Oslo) and from biotech/pharmaceutical industry (more than 25 years at Alpharma/Xellia Pharmaceuticals). Special expertise within the antiinfective and the anticancer drug segment, preclinical drug development, project management, business intelligence, portfolio management and international business development. He has served as a board member of MarBiLeads since 2013. Other appointments include member of the Board of Directors of Biosergen AS and of Orpedion AS.

e-mail: omgulliksen@marbileads.com



Geir Klinkenberg 
– Project Manager R&D. Biotechnologist.

Geir is Senior research scientist at SINTEF Materials and Chemistry, Dept. of Biotechnology and Nanomedicine where he has gained extensive experience within drug discovery, cell based assays, high throughput screening, mass spectrometry and metabolite analysis. He has been working with marine bioprospecting since 2003 and is the responsible scientist for the high throughput screening laboratory at SINTEF Materials and Chemistry. As such Geir brings experience from a large number of projects both for the industry and public financed research projects.



Kristin F. Degnes 
– Project Research Associate. Biotechnologist.

Kristin Fløgstad Degnes has worked as research scientist at SINTEF Materials and Chemistry, Dept. of Biotechnology and Nanomedicine since 2004. Her main fields are within drug discovery, biopharmaceuticals and metabolomics. She has many years of experience within high resolution LC-MS analyses, compound identification, HPLC purifications of compounds and cultivations of Actinobacteria. Her work has resulted in 15 peer-reviewed publications and three patents (by May 2016).